Top accelerator startups

14,448 startups · 29 programs

Forcyte Biotechnologies

Inactive · Discover drugs that control how much cells "squeeze" to treat disease

2signal of 100 · rising 0
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from W21

All of W21

About Forcyte Biotechnologies

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

YC batch
W21 · Winter 2021
Status, per YC
Inactive
Category
Other
Team size
5
Location
Los Angeles, CA, USA
Checked
7h ago

YC tags: Drug discovery

Forcyte Biotechnologies in W21: 336 companies, 30% AI

Forcyte Biotechnologies: questions

Which YC batch was Forcyte Biotechnologies in?

Forcyte Biotechnologies was in Y Combinator's Winter 2021 batch (W21).

Is Forcyte Biotechnologies still active?

Y Combinator lists Forcyte Biotechnologies as inactive.

Where is Forcyte Biotechnologies based?

Forcyte Biotechnologies lists Los Angeles, CA, USA as its location on YC's directory.